Copyright
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. May 16, 2022; 10(14): 4414-4424
Published online May 16, 2022. doi: 10.12998/wjcc.v10.i14.4414
Published online May 16, 2022. doi: 10.12998/wjcc.v10.i14.4414
Evaluation of short- and medium-term efficacy and complications of ultrasound-guided ablation for small liver cancer
Hua Zhong, Rong Hu, Yun-Shan Jiang, Department of Ultrasound Medicine, The Central Hospital of Yongzhou, Yongzhou 425000, Hunan Province, China
Author contributions: Zhong H designed the study; Hu R drafted the work; Jiang YS and Zhong H collected the data; Hu R analyzed and interpreted data; Jiang YS and Zhong H wrote and revised the manuscript.
Institutional review board statement: This study was approved by the Ethics Committee of The Central Hospital of Yongzhou.
Informed consent statement: Patients were not required to give informed consent to the study because the analysis used anonymous clinical data that were obtained after each patient agreed to treatment by written consent.
Conflict-of-interest statement: The authors declared that there is no conflict of interest between them.
Data sharing statement: No additional data are available.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Yun-Shan Jiang, MD, Chief Doctor, Department of Ultrasound Medicine, The Central Hospital of Yongzhou, No. 151 Xiaoshui West Road, Yongzhou 425000, Hunan Province, China. jys1111112021@163.com
Received: November 21, 2021
Peer-review started: November 21, 2021
First decision: December 9, 2021
Revised: December 19, 2021
Accepted: March 14, 2022
Article in press: March 14, 2022
Published online: May 16, 2022
Peer-review started: November 21, 2021
First decision: December 9, 2021
Revised: December 19, 2021
Accepted: March 14, 2022
Article in press: March 14, 2022
Published online: May 16, 2022
Core Tip
Core Tip: Through a set of controls, it was confirmed that the effect of ultrasound-guided percutaneous microwave ablation in the treatment of small liver cancer is similar to that of laparoscopic surgery. However, ablation will also cause less trauma and liver dysfunction, so there is more room for development in clinical applications.